CD16-II variants
AssigneeApplied Research Systems ARS Holding N.V.
InventorShun Luo
Life of this patent
Estimating the term…
Abstract
Human CD16-II variants, DNA sequences coding for them, their use in therapy and/or in diagnosis of autoimmune diseases and inflammatory illnesses, as well as pharmaceutical compositions comprising them, are disclosed. The sequence listing for the new polypeptides is provided.
Claims10
An isolated CD16II protein comprising an amino acid sequence selected from the group consisting of the amino acid sequence of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 and SEQ ID NO:4.
An isolated CD16-II protein comprising the amino acid sequence of sequence SEQ ID No. 1.
An isolated CD16-II protein comprising the amino acid sequence of sequence SEO ID No. 2.
An isolated CD16 II protein comprising the amino acid sequence of sequence SEQ ID No. 3.
An isolated CD16 II protein comprising the amino acid sequence of sequence SEQ ID No. 4.
Dependencies are inferred from the claim text.